Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for NSAID-induced small bowel enteropathy (capsule endoscopy pilot)
2007-001317-42Phase 2Completed
- Sponsor
- Prof. Dr. Istvan Racz
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Salcrozine in Small bowel enteropathy (SBE), sponsored by Prof. Dr. Istvan Racz. Primary endpoint: Mucosal healing rate by seven-point score on video capsule endoscopy. Started Jan 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
Small bowel enteropathy (SBE)
Beyond the preview
Go deeper on 2007-001317-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001317-42.